Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000054

President & COO sold 2,303 shares at an average $15.09 ($34,753)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2024-09-06 Sale 10b5-1 −399 $15.19 $6,063 127,900 D: show line 1 in the form
Dowden Nathan J President & COO 2024-09-09 Sale 10b5-1 −1,904 $15.07 $28,690 125,996 D: show line 2 in the form
Open-market sales · 2,303 sh · avg $15.09 · $34,753
Loading xslF345X05/wk-form4_1726000407.xml…